LEP and cancer: Several studies have reported that leptin and leptin receptor are implicated in cancer, mainly via the JAK/STAT pathway, which regulates PI3K/AKT3 and ERK1/2 signaling, angiogenic factors (VEGF), systemic inflammation (TNF-α, IL6), and anti-apoptotic proteins (XIAP) expression [98].